Boston Scientific Reaches $38.5M Deal To End Investor Suit

By Brian Dowling · December 15, 2023, 6:45 PM EST

Investors suing Boston Scientific Inc. for touting a heart valve product that was later pulled from the market announced Friday that they have settled their stock suit against the medical device...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

In re Boston Scientific Corporation Securities Litigation

Case Number

Court

Massachusetts

Nature of Suit

Stockholders Suits

Date Filed

December 16, 2020

Recent Articles By Brian

May 29, 2024
Whistleblower Counsel Can't Get 'Exorbitant' $11.5M Fee
May 17, 2024
FCA Relators Seek Finders Fee For SpineFrontier Doc Deals
May 17, 2024
Mass. Hospital Pays $24.3M To Settle Heart-Surgery FCA Case
May 16, 2024
Ex-Pharma Exec Cops To Contempt For Barred Finance Work
April 22, 2024
Dentist Must Face Harassment Suit, Mass. Panel Says
March 28, 2024
Implant Maker's Bribe Case Ripe For Trimming, Judge Says
March 26, 2024
Ex-Veterans Home Leaders Resolve Landmark COVID-19 Case
March 14, 2024
Feds Seek 20 Mos. For Aegerion Fraud 'Puppet Master'
February 28, 2024
NuVasive Can Pierce Co. To Collect From Ex-Rep, Judge Says
February 09, 2024
23andMe Led To Late Father And $28M Verdict, Woman Says